MacDiarmid SA, et al. (2008). Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: Randomized, double-blind, placebo-controlled study. Mayo Clinic Proceedings, 83(9): 1002–1010.
Kaplan SA, et al. (2006). Tolterodine and tamsulosin
for treatment of men with lower urinary tract symptoms and overactive bladder.
JAMA, 296(19): 2319–2328.
Other Works Consulted
Chapple CR, Milson I (2012). Urinary incontinence and pelvic prolapse: Epidemiology and pathophysiology. In AJ Wein et al., eds., Campbell-Walsh Urology, 10th ed., vol. 3, pp. 1871–1895. Philadelphia: Saunders.
Herschorn S (2012). Injection therapy for urinary incontinence. In AJ Wein et al., eds., Campbell-Walsh Urology, 10th ed., vol. 3, pp. 2168–2185. Philadelphia: Saunders.
Naumann M, et al. (2008). Assessment: Botulinum
neurotoxin in the treatment of autonomic disorders and pain (an evidence-based
review): Report of the Therapeutics and Technology Assessment Subcommittee of
the American Academy of Neurology. Neurology, 70(19):
Resnick, NM (2012). Incontinence. In L Goldman, A Shafer, eds., Goldman's Cecil Medicine, 24th ed., pp. 110–114. Philadelphia: Saunders.
Silva LA, et al. (2011). Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database of Systematic Reviews (4).
Wadie BS (2010). Retropubic bulbourethral sling for post-prostatectomy male incontinence: 2-year followup. Journal of Urology, 184(6): 2446–2451.
WebMD Medical Reference from Healthwise
September 09, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this